Carl C. Peck

4.9k total citations · 1 hit paper
108 papers, 3.3k citations indexed

About

Carl C. Peck is a scholar working on Pediatrics, Perinatology and Child Health, Statistics and Probability and Economics and Econometrics. According to data from OpenAlex, Carl C. Peck has authored 108 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pediatrics, Perinatology and Child Health, 30 papers in Statistics and Probability and 21 papers in Economics and Econometrics. Recurrent topics in Carl C. Peck's work include Statistical Methods in Clinical Trials (30 papers), Pharmaceutical studies and practices (26 papers) and Health Systems, Economic Evaluations, Quality of Life (18 papers). Carl C. Peck is often cited by papers focused on Statistical Methods in Clinical Trials (30 papers), Pharmaceutical studies and practices (26 papers) and Health Systems, Economic Evaluations, Quality of Life (18 papers). Carl C. Peck collaborates with scholars based in United States, United Kingdom and Switzerland. Carl C. Peck's co-authors include Malcolm Rowland, Geoffrey T. Tucker, Lewis B. Sheiner, Phillip W. Albro, Alice I. Nichols, Terrence F. Blaschke, Nicholas H. G. Holford, Lawrence J. Lesko, L Balant and Jonathan Monteleone and has published in prestigious journals such as New England Journal of Medicine, Nature Immunology and American Journal of Clinical Nutrition.

In The Last Decade

Carl C. Peck

106 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Physiologically-Based Pharmacokinetics in Drug Development and Regulatory Science

2011 465 citations Malcolm Rowland, Carl C. Peck et al. profile →

Peers

Carl C. Peck

PHARM

PPCH

ONCOL

E. Niclas Jonsson Sweden

Issam Zineh United States

Thomas M. Ludden United States

Jörg Lippert Germany

Russell A. Wilke United States

Stefan Willmann Germany

Anke H. Maitland‐van der Zee Netherlands

Felix W. Frueh United States

I. Ralph Edwards Sweden

Joseph A. Grillo United States

E. Niclas Jonsson Sweden

Carl C. Peck

762 ×1.1

PHARM

864 ×1.3

825 ×1.4

PPCH

754 ×1.5

933 ×2.4

ONCOL

Citations per year, relative to Carl C. Peck Carl C. Peck (= 1×) peers E. Niclas Jonsson

Countries citing papers authored by Carl C. Peck

Since Specialization

Citations

This map shows the geographic impact of Carl C. Peck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl C. Peck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl C. Peck more than expected).

Fields of papers citing papers by Carl C. Peck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl C. Peck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl C. Peck. The network helps show where Carl C. Peck may publish in the future.

Co-authorship network of co-authors of Carl C. Peck

This figure shows the co-authorship network connecting the top 25 collaborators of Carl C. Peck. A scholar is included among the top collaborators of Carl C. Peck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl C. Peck. Carl C. Peck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Xiaofang, Carl C. Peck, Yaning Wang, et al.. (2024). Strength of clinical evidence supporting the United States Food and Drug Administration Accelerated Approvals from 2015 to 2022. BMC Medicine. 22(1). 587–587.

Feigal, Ellen G., et al.. (2019). At the end of the beginning: immunotherapies as living drugs. Nature Immunology. 20(8). 955–962. 4 indexed citations

Peck, Carl C., et al.. (2016). Determination of the starting dose in the first-in-human clinical trials with monoclonal antibodies: a systematic review of papers published between 1990 and 2013. Drug Design Development and Therapy. Volume 10. 4005–4016. 21 indexed citations

Peck, Carl C. & James T. Cross. (2007). “Getting the Dose Right”: Facts, a Blueprint, and Encouragements. Clinical Pharmacology & Therapeutics. 82(1). 12–14. 24 indexed citations

Ratain, Mark J., Rachel Humphrey, Gary Gordon, et al.. (2007). Recommended changes to oncology clinical trial design: Revolution or evolution?. European Journal of Cancer. 44(1). 8–11. 31 indexed citations

Rolan, Paul, Meindert Danhof, Donald Stanski, & Carl C. Peck. (2006). Current issues relating to drug safety especially with regard to the use of biomarkers: A meeting report and progress update. European Journal of Pharmaceutical Sciences. 30(2). 107–112. 7 indexed citations

Wertheim, Eleanor H., et al.. (2006). Skills for Resolving Conflict : Creating Effective Solutions Through Co-operative Problem Solving. Victoria University Research Repository (Victoria University). 4 indexed citations

Tannenbaum, Stacey, Nicholas H. G. Holford, Howard Lee, Carl C. Peck, & Diane R. Mould. (2006). Simulation of Correlated Continuous and Categorical Variables using a Single Multivariate Distribution. Journal of Pharmacokinetics and Pharmacodynamics. 33(6). 773–794. 35 indexed citations

Lee, Howard, Dong‐Seok Yim, Honghui Zhou, & Carl C. Peck. (2005). Evidence of effectiveness: How much can we extrapolate from existing studies?. The AAPS Journal. 7(2). E467–E474. 14 indexed citations

10.

Spyker, Daniel A., Emily Harvey, Barry H. Rumack, et al.. (2000). Assessment and reporting of clinical pharmacology information in drug labeling. Clinical Pharmacology & Therapeutics. 67(3). 196–200. 18 indexed citations

11.

Lesko, Lawrence J., Malcolm Rowland, Carl C. Peck, & Terrence F. Blaschke. (2000). Optimizing the science of drug development: opportunities for better candidate selection and accelerated evaluation in humans. European Journal of Pharmaceutical Sciences. 10(4). iv–xiv. 35 indexed citations

12.

Tuk, Bert, Janine Oberyé, Monique S. M. Pieters, et al.. (1997). Pharmacodynamics of temazepam in primary insomnia: Assessment of the value of quantitative electroencephalography and saccadic eye movements in predicting improvement of sleep. Clinical Pharmacology & Therapeutics. 62(4). 444–452. 12 indexed citations

13.

Peck, Carl C., William H. Barr, Leslie Z. Benet, et al.. (1992). Opportunities for Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug Development. Journal of Pharmaceutical Sciences. 81(6). 605–610. 49 indexed citations

14.

Conner, Dale P., et al.. (1991). Transcutaneous Chemical Collection of Caffeine in Normal Subjects: Relationship to Area Under the Plasma Concentration-Time Curve and Sweat Production. Journal of Investigative Dermatology. 96(2). 186–190. 13 indexed citations

15.

Conner, Dale P., et al.. (1989). Transcutaneous Collection of Theophylline: Constancy and Linearity of Skin Permeability. Skin Pharmacology and Physiology. 2(3). 155–161. 5 indexed citations

16.

Peck, Carl C.. (1984). Evaluating the survival of stored red cells. Transfusion. 24(2). 97–99. 7 indexed citations

17.

Peck, Carl C. & Phillip W. Albro. (1982). Toxic potential of the plasticizer Di(2-ethylhexyl) phthalate in the context of its disposition and metabolism in primates and man.. Environmental Health Perspectives. 45. 11–17. 104 indexed citations

18.

Peck, Carl C., et al.. (1981). An Aminoglycoside Dosing Program Using a Bayesian Algorithm. Annual Symposium on Computer Application in Medical Care. 82(5). 610–613. 4 indexed citations

19.

Albro, Phillip W., et al.. (1981). Identification of the metabolites of di-(2-ethylhexyl) phthalate in urine from the African green monkey.. Drug Metabolism and Disposition. 9(3). 223–225. 54 indexed citations

20.

Peck, Carl C., William D. Brown, Lewis B. Sheiner, & Brian G. Schuster. (1980). A Microcomputer Drug (Theophylline) Dosing Program Which Assists and Teaches Physicians. PubMed Central. 2. 988–994. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact